Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 141.6B, Pfizer(PFE) trades at $24.85. The stock has a price-to-earnings ratio of 19.27 and currently yields dividends of 6.84%.
During the trading session on 2026-07-20, Pfizer(PFE) shares reached a daily high of $25.16 and a low of $24.80. At a current price of $24.85, the stock is +0.2% higher than the low and still -1.2% under the high.
Trading volume for Pfizer(PFE) stock has reached 18.96M, versus its average volume of 42.12M.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
PFE News
U.S. pharmaceutical giant Pfizer Inc. (NYSE:PFE) has paused the distribution of its Premarin vaginal cream in India. The temporary halt significantly reduces t...
Key Points Pfizer has an attractive weight loss pipeline. However, it will be hard to take the lead from other companies in this fast-growing area. There are...
Key Points Pfizer is deeply out of favor today, with a historically high dividend yield of 6.9%. The company is dealing with headwinds, but they are pretty no...
Analyst ratings
62%
of 29 ratingsMore PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has...
Artificial intelligence in healthcare is attracting fresh attention as investors weigh inflation trends, shifting interest rate expectations, and volatile energ...
Pfizer (PFE) is back in focus after the U.S. Food and Drug Administration approved PADCEV plus Keytruda as a platinum free neoadjuvant and adjuvant regimen for...
Arbutus Biopharma (ABUS) and Genevant Sciences, a subsidiary of Roivant Sciences (ROIV), on Thursday announced the filing of three international lawsuits over a...
Arbutus Biopharma (ABUS) and its exclusive licensee, Genevant Sciences, a subsidiary of Roivant (ROIV), announced the filing of three international lawsuits see...
Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price By Vandita Jadeja Published Jul 15, 1:29PM EDT Quick Read JNJ earns a B...
This lithium producer surpassed a $1B private valuation, joining some of America's most powerful startups. Now you can invest in EnergyX alongside global giants...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.